University of Wisconsin–Madison

(SEAL) Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis

This project was led by: Keith Meyer MD

This project was funded by: Bristol-Myers Squibb

The term of this project was: March 2015 to December 2017

The number of subjects scanned during this project was: 30